Literature DB >> 8409389

Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells.

J N Siegel1, C H June, H Yamada, U R Rapp, L E Samelson.   

Abstract

The c-Raf-1 serine/threonine kinase is an important component of signal transduction pathways mediating the effects of a variety of growth factors. In activated T cells, IL-2 has been shown to induce activation of c-Raf-1, but c-Raf-1 has not previously been shown to be activated through the T-cell receptor (TCR) in resting G0 T cells. Using a sensitive immune complex kinase reaction, we show that cross-linking of the stimulatory and costimulatory receptors CD3, CD4, or CD28 induces c-Raf-1 activation in highly purified resting peripheral blood human T cells. In contrast, cross-linking the nonstimulatory receptor CD45 did not induce c-Raf-1. Surprisingly, although earlier studies had shown delayed kinetics in response to Thy-1 stimulation in murine cells, c-Raf-1 activation in response to CD3 cross-linking was one of the earliest measurable events. In spite of its early kinetics, c-Raf-1 activation was found to be downstream of several other early signal transduction events, including activation of a tyrosine kinase and a tyrosine phosphatase. Several lines of evidence suggest that activation of c-Raf-1 in response to TCR stimulation may be PKC-dependent: first, phorbol esters are extremely potent activators of c-Raf-1 in human T cells; second, the kinetics of accumulation of products of phosphatidylinositol hydrolysis coincides with the kinetics of c-Raf-1 activation; and third, physiologic activation of the PLC/PKC pathway through a transfected, G-protein-coupled receptor HM1 induced similar levels of c-Raf-1 activation with a similar time course. We conclude that c-Raf-1 activation is tightly coupled to TCR stimulation and may participate in signal transduction pathways in resting, G0 T cells. The observation that the HM1 receptor can also activate c-Raf-1 suggests that T cells have the capability to utilize both tyrosine kinase-dependent and tyrosine kinase-independent mechanisms of c-Raf-1 activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

2.  GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction.

Authors:  A Avots; A Hoffmeyer; E Flory; A Cimanis; U R Rapp; E Serfling
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

3.  Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes.

Authors:  E Flory; C K Weber; P Chen; A Hoffmeyer; C Jassoy; U R Rapp
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.

Authors:  S P Sidorenko; C L Law; K A Chandran; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

Review 5.  Role of corticosterone in immunosuppressive effects of acute ethanol exposure on Toll-like receptor mediated cytokine production.

Authors:  Mitzi Glover; Stephen B Pruett
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-04       Impact factor: 4.147

6.  RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.

Authors:  J H Lai; G Horvath; J Subleski; J Bruder; P Ghosh; T H Tan
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 7.  Modulation of immunity by antiangiogenic molecules in cancer.

Authors:  Magali Terme; Orianne Colussi; Elie Marcheteau; Corinne Tanchot; Eric Tartour; Julien Taieb
Journal:  Clin Dev Immunol       Date:  2012-12-24

8.  The role of Raf-1 in the regulation of extracellular signal-regulated kinase 2 by the T cell antigen receptor.

Authors:  M Izquierdo; S Bowden; D Cantrell
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

9.  The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras.

Authors:  J A Nunès; Y Collette; A Truneh; D Olive; D A Cantrell
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  CD28 signals through acidic sphingomyelinase.

Authors:  L M Boucher; K Wiegmann; A Fütterer; K Pfeffer; T Machleidt; S Schütze; T W Mak; M Krönke
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.